Feng, Mingye
Jiang, Wen http://orcid.org/0000-0001-9154-633X
Kim, Betty Y. S. http://orcid.org/0000-0001-6890-8355
Zhang, Cheng Cheng
Fu, Yang-Xin http://orcid.org/0000-0002-4809-825X
Weissman, Irving L. http://orcid.org/0000-0002-9077-7467
Article History
Accepted: 15 July 2019
First Online: 28 August 2019
Competing interests
: I.L.W. is a co-founder and director of, holds equity in and has multiple patents licensed to Forty Seven Inc. M.F. declares patent applications pertaining to stimulating TLR/BTK signalling to promote calreticulin in macrophages (assigned to the Stanford University) and holds equity with Forty Seven Inc. The other authors declare no competing interests. C.C.Z. is a scientific founder of, holds equity in and has multiple patents licensed to Immune-Onc Therapeutics.